452 related articles for article (PubMed ID: 16465384)
1. Enhancing the photodynamic effect of hypericin in human bladder transitional cell carcinoma spheroids by the use of the oxygen carrier, perfluorodecalin.
Kamuhabwa AR; Huygens A; Roskams T; De Witte PA
Int J Oncol; 2006 Mar; 28(3):775-80. PubMed ID: 16465384
[TBL] [Abstract][Full Text] [Related]
2. Enhancing the photodynamic effect of hypericin in tumour spheroids by fractionated light delivery in combination with hyperoxygenation.
Huygens A; Kamuhabwa AR; Van Laethem A; Roskams T; Van Cleynenbreugel B; Van Poppel H; Agostinis P; De Witte PA
Int J Oncol; 2005 Jun; 26(6):1691-7. PubMed ID: 15870887
[TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy of transitional cell carcinoma multicellular tumor spheroids with hypericin.
Kamuhabwa AA; Huygens A; De Witte PA
Int J Oncol; 2003 Nov; 23(5):1445-50. PubMed ID: 14532989
[TBL] [Abstract][Full Text] [Related]
4. In vivo photodynamic activity of hypericin in transitional cell carcinoma bladder tumors.
Zupkó I; Kamuhabwa AR; D'Hallewin MA; Baert L; De Witte PA
Int J Oncol; 2001 May; 18(5):1099-105. PubMed ID: 11295062
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic activity of hypericin in human urinary bladder carcinoma cells.
Kamuhabwa AR; Agostinis P; D'Hallewin MA; Kasran A; de Witte PA
Anticancer Res; 2000; 20(4):2579-84. PubMed ID: 10953329
[TBL] [Abstract][Full Text] [Related]
6. Permeation of hypericin in spheroids composed of different grade transitional cell carcinoma cell lines and normal human urothelial cells.
Huygens A; Kamuhabwa AR; Roskams T; VAN Cleynenbreugel B; VAN Poppel H; de Witte PA
J Urol; 2005 Jul; 174(1):69-72. PubMed ID: 15947580
[TBL] [Abstract][Full Text] [Related]
7. Human serum albumin as key mediator of the differential accumulation of hypericin in normal urothelial cell spheroids versus urothelial cell carcinoma spheroids.
Roelants M; Van Cleynenbreugel B; Lerut E; Van Poppel H; de Witte PA
Photochem Photobiol Sci; 2011 Jan; 10(1):151-9. PubMed ID: 21103512
[TBL] [Abstract][Full Text] [Related]
8. Hypericin as a potential phototherapeutic agent in superficial transitional cell carcinoma of the bladder.
Kamuhabwa A; Agostinis P; Ahmed B; Landuyt W; van Cleynenbreugel B; van Poppel H; de Witte P
Photochem Photobiol Sci; 2004 Aug; 3(8):772-80. PubMed ID: 15295634
[TBL] [Abstract][Full Text] [Related]
9. Differential accumulation of hypericin in spheroids composed of T-24 transitional cell carcinoma cells expressing different levels of E-cadherin.
Huygens A; Crnolatac I; Develter J; Van Cleynenbreugel B; Van der Kwast T; de Witte PA
J Urol; 2008 May; 179(5):2014-9. PubMed ID: 18355860
[TBL] [Abstract][Full Text] [Related]
10. Whole bladder wall photodynamic therapy of transitional cell carcinoma rat bladder tumors using intravesically administered hypericin.
Kamuhabwa AA; Roskams T; D'Hallewin MA; Baert L; Van Poppel H; de Witte PA
Int J Cancer; 2003 Nov; 107(3):460-7. PubMed ID: 14506748
[TBL] [Abstract][Full Text] [Related]
11. Molecular effectors and modulators of hypericin-mediated cell death in bladder cancer cells.
Buytaert E; Matroule JY; Durinck S; Close P; Kocanova S; Vandenheede JR; de Witte PA; Piette J; Agostinis P
Oncogene; 2008 Mar; 27(13):1916-29. PubMed ID: 17952126
[TBL] [Abstract][Full Text] [Related]
12. Hypericin activated by an incoherent light source has photodynamic effects on esophageal cancer cells.
Höpfner M; Maaser K; Theiss A; Lenz M; Sutter AP; Kashtan H; von Lampe B; Riecken EO; Zeitz M; Scherübl H
Int J Colorectal Dis; 2003 May; 18(3):239-47. PubMed ID: 12673490
[TBL] [Abstract][Full Text] [Related]
13. Cellular and molecular mechanisms of photodynamic hypericin therapy for nasopharyngeal carcinoma cells.
Wang X; Guo Y; Yang S; Wang C; Fu X; Wang J; Mao Y; Zhang J; Li Y
J Pharmacol Exp Ther; 2010 Sep; 334(3):847-53. PubMed ID: 20551295
[TBL] [Abstract][Full Text] [Related]
14. Hypericin-mediated photocytotoxic effect on HT-29 adenocarcinoma cells is reduced by light fractionation with longer dark pause between two unequal light doses.
Sacková V; Kuliková L; Mikes J; Kleban J; Fedorocko P
Photochem Photobiol; 2005; 81(6):1411-6. PubMed ID: 16354114
[TBL] [Abstract][Full Text] [Related]
15. Microscopic quantification of hypercin fluorescence in an orthotopic rat bladder tumor model after intravesical instillation.
Kamuhabwa AA; Roskams T; Baert L; De Witte PA
Int J Oncol; 2003 Apr; 22(4):933-7. PubMed ID: 12632090
[TBL] [Abstract][Full Text] [Related]
16. In vitro photodynamic therapy in pediatric epithelial liver tumors promoted by hypericin.
Seitz G; Krause R; Fuchs J; Heitmann H; Armeanu S; Ruck P; Warmann SW
Oncol Rep; 2008 Nov; 20(5):1277-82. PubMed ID: 18949433
[TBL] [Abstract][Full Text] [Related]
17. Enhancing the antitumoral effect of hypericin-mediated photodynamic therapy by hyperthermia.
Chen B; Roskams T; de Witte PA
Lasers Surg Med; 2002; 31(3):158-63. PubMed ID: 12224088
[TBL] [Abstract][Full Text] [Related]
18. Hypericin-photodynamic therapy (PDT) using an alternative treatment regime suitable for multi-fraction PDT.
Thong PS; Watt F; Ren MQ; Tan PH; Soo KC; Olivo M
J Photochem Photobiol B; 2006 Jan; 82(1):1-8. PubMed ID: 16203156
[TBL] [Abstract][Full Text] [Related]
19. Antitumour activity of photosensitized hypericin on A431 cell xenografts.
Vandenbogaerde AL; Geboes KR; Cuveele JF; Agostinis PM; Merlevede WJ; De Witte PA
Anticancer Res; 1996; 16(4A):1619-25. PubMed ID: 8712679
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Hypocrellin B in a human bladder tumor model in experimental photodynamic therapy: biodistribution, light dose and drug-light interval effects.
Chin W; Lau W; Cheng C; Olivo M
Int J Oncol; 2004 Sep; 25(3):623-9. PubMed ID: 15289863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
